# Pazopanib Maintenance for SCLC

> **NCT01797874** · PHASE2 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 97 (actual)

## Conditions studied

- SCLC

## Interventions

- **DRUG:** Pazopanib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01797874
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2017-02
- **Final completion:** 2017-12
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2019-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01797874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01797874, "Pazopanib Maintenance for SCLC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01797874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*